Drawing for BIONANO GENOMICS

USPTO serial 86361387

BIONANO GENOMICS

Reviewed by CopyMark Law Group

Reg. 5076021Status 710
Filing date
Status date
Registration date
Nov 8, 2016
Examiner
DWYER, JOHN D
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with BIONANO GENOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Ian W. Gillies

IAN W. GILLIES Knobbe Martens Olson & Bear Llp2040 Main St Fl 14Irvine, CA 92614-8214UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Reagents for use in preparing molecules for genomic research and analysis; a kit for extracting and labeling biopolymers for research purposes, containing enzymes, color reagents, buffers, and other reagents; Polynucleotide isolation and purification kit consisting of enzymes, color reagents, buffers, and other reagents used for scientific or medical research purposes; kits for extracting and labeling polynucleotide molecules for research purposes, containing enzymes, color reagents, buffers, and other reagents; reagents for use in preparing polynucleotide molecules for genomic research; diagnostic kits containing enzymes, color reagents, buffers, and other reagents for extracting and labeling polynucleotide moleculesSECTION 8 - CANCELLEDMay 13, 2013
005Reagents for use in clinical medicine for preparing molecules for genomic analysis; a medical diagnostic kit containing enzymes, color reagents, buffers, and other reagents for extracting and labeling biopolymersSECTION 8 - CANCELLEDMay 13, 2013
009An imaging system, namely, an imaging apparatus and software, for the analysis of biopolymer samples in scientific or medical research; software used in the analysis of biopolymer samples for medical diagnostic purposes; software used in the analysis of biopolymer samples for scientific or medical research; an imaging apparatus for use in the analysis of biopolymer samples in scientific or medical research; Nanofluidic devices, namely, solid state substrates in the nature of plates, chips and wafers, and software, both of the foregoing for genomic imaging and analysis;An imaging apparatus and software for genomic analysis in scientific or medical research; an imaging system, namely, an imaging apparatus and software sold as a unit, for genomic analysis in scientific or medical research; software for genomic analysis used for medical diagnostic purposes; Genomic data analysis software; software for interpreting and analyzing data generated by an imaging apparatus for the purpose of studying biopolymer samples; Solid state substrates, namely, plates, chips, and wafers for use in scientific or medical research, having a pattern of channels for confining and linearizing biopolymer samples; disposable substrates, namely, plates, chips, and wafers for use in scientific or medical research, having a pattern of channels to facilitate genomic imaging and analysis; Solid state substrates, namely, plates, chips and wafers having a plurality of fluid passageways for confining and linearizing macromolecules including biopolymer molecules for scientific or medical research; nanochannel wafers, for scientific or medical research, used in instruments for genomic analysisSECTION 8 - CANCELLEDSep 30, 2012
010A medical diagnostic imaging system, namely, an imaging apparatus and software sold as a unit and used in the analysis of biopolymer samples; a medical diagnostic imaging apparatus used in the analysis of biopolymer samples; A medical diagnostic imaging system, namely, an imaging apparatus and software sold as a unit for genomic analysis; a medical imaging apparatus for genomic analysis; Solid state substrates, namely, plates, chips, and wafers for use in clinical medicine, having a pattern of channels for confining and linearizing biopolymer samples; disposable substrates, namely, plates, chips, and wafers for use in clinical medicine, having a pattern of channels to facilitate genomic imaging and analysis; Medical diagnostic solid state substrates, namely, plates, chips and wafers for confining and linearizing macromolecules including biopolymer molecules; nanochannel wafers, for use in clinical medicine, used in instruments for genomic analysisSECTION 8 - CANCELLEDSep 30, 2012
042Product research and development and consulting services for others in the fields of biopolymer imaging and analysis; genomic mapping, genomic imaging, and genomic analysis services for scientific research purposesSECTION 8 - CANCELLEDJun 13, 2012

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 19, 2023C8..CANCELLED SEC. 8 (6-YR)—
Nov 8, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 21, 2019CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 21, 2019COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 19, 2018ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Nov 8, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 23, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 23, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 3, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 20, 2016PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 13, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 22, 2016RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Dec 19, 2015RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 19, 2015GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jun 19, 2015GNSLLETTER OF SUSPENSION E-MAILED—
Jun 19, 2015CNSLSUSPENSION LETTER WRITTEN—
Jun 19, 2015ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jun 10, 2015JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Apr 9, 2015ISERWITHDRAWN FROM ISSUE - EXAMINING ATTORNEY REQUEST—
Apr 7, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 7, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 18, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 3, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Mar 3, 2015ALIEASSIGNED TO LIE—
Feb 12, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 12, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 11, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 11, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 29, 2014GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2014GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 29, 2014CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 23, 2014DOCKASSIGNED TO EXAMINER—
Aug 20, 2014MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Aug 19, 2014NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 12, 2014NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance